Phase III Study of ASP2151 in Herpes Simplex Patients

NCT01959295 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

468

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Simplex

Interventions

DRUG: ASP2151
DRUG: ASP2151 placebo

Sponsor

Maruho Co., Ltd.